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ABSTRACT
Background and Purpose. Caveolae act as signalling hubs in endothelial and
smooth muscle cells. Caveolar disruption by the membrane cholesterol depleting
agent methyl-β-cyclodextrin (M-β-CD) has various functional effects on arteries
including (i) impairment of endothelium-dependent relaxation, and (ii) alteration of
smooth muscle cell (SMC) contraction independently of the endothelium. The aim
of this study was to explore the effects of M-β-CD on rat femoral arteries.
Methods. Isometric force was measured in rat femoral arteries stimulated to contract
with a solution containing 20 mM K+ and 200 nM Bay K 8644 (20 K/Bay K) or with
one containing 80 mM K+ (80 K).
Results. Incubation of arteries with M-β-CD (5 mM, 60 min) increased force in
response to 20 K/Bay K but not that induced by 80 K. Application of cholesterol
saturated M-β-CD (Ch-MCD, 5 mM, 50 min) reversed the effects of M-β-CD. After
mechanical removal of endothelial cells M-β-CD caused only a small enhancement
of contractions to 20 K/Bay K. This result suggests M-β-CD acts via altering release
of an endothelial-derived vasodilator or vasoconstrictor. When nitric oxide synthase
was blocked by pre-incubation of arteries with L-NAME (250 µM) the contraction of
arteries to 20 K/Bay K was enhanced, and this effect was abolished by pre-treatment
with M-β-CD. This suggests M-β-CD is inhibiting endothelial NO release. Inhibi-
tion of large conductance voltage- and Ca2+-activated (BKCa) channels with 2 mM
TEA+ or 100 nM Iberiotoxin (IbTX) enhanced 20 K/Bay K contractions. L-NAME
attenuated the contractile effect of IbTX, as did endothelial removal.
Conclusions. Our results suggest caveolar disruption results in decreased release
of endothelial-derived nitric oxide in rat femoral artery, resulting in a reduced
contribution of BKCa channels to the smooth muscle cell membrane potential,
causing depolarisation and contraction.
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INTRODUCTION
Caveolae are flask shaped invaginations, 50–100 nm in diameter, present in the plasma
membrane of endothelial cells (ECs) and smooth muscle cells (SMCs) (Cohen et al.,
2004). Caveolae have been implicated in cell signalling and transport processes in the
vasculature, with roles that include the regulation of contractility, trans-endothelial
transport and cholesterol metabolism (Cohen et al., 2004). Many of the functions of
caveolae are attributed to the caveolin family of proteins, of which cavolin-1 is the most
widely expressed subtype (Cohen et al., 2004).
Disruption of caveolae causes arterial contractility to change by acting on both ECs and
SMCs. Disruption of endothelial caveolae by cholesterol depleting agents such as M-β-CD
and filipin reduces responses to endothelial-dependent vasodilators (Darblade et al., 2001;
Xu et al., 2008). Caveolin-1 has a tonic inhibitory effect on endothelial NO synthase
(eNOS) activity, and it is thought that on cholesterol-depletion caveolin-1 re-distributes
from caveolar to non-caveolar membranes (Xu et al., 2008). This results in a reduction
in eNOS activation in response to endothelium-dependent vasodilators, possibly due to
disrupted organisation of signalling complexes normally located in caveolae (Xu et al.,
2008). As well as regulating NO synthesis, caveolae are implicated in the response to other
endothelium-derived vasodilators including endothelial derived hyperpolarising factor
(EDHF) (Graziani et al., 2004; Xu et al., 2007). Caveolar disruption may underlie the
reduced endothelium-dependent vasodilation seen in a number of diseases, including
atherosclerosis (Darblade et al., 2001; Xu et al., 2008).
Caveolae in SMCs also regulate contractility (e.g., Razani et al., 1990; Dreja et al., 2002;
Potoknik et al., 2007). The response to some vasoconstrictors (e.g., 5-hydroxytryptamine,
endothelin-1) is reduced after caveolar disruption (Dreja et al., 2002; Prendergast et al.,
2010), although the response to elevated extracellular K+ and to α-adrenergic agonists is
generally unaffected (Dreja et al., 2002; Prendergast et al., 2010; though see Je et al., 2004).
Myogenic tone that develops in response to pressurization of small resistance-sized arteries
is reduced (Dubroca et al., 2007; Potoknik et al., 2007). Caveolar disruption may lead to a
reduced responsiveness to vasoconstrictors and pressure via loss of caveolar localisation
of signal transduction pathways (e.g., Clarke, Ohanian & Ohanian, 2007; Dubroca et al.,
2007), ion channels (e.g., Sampson et al., 2007) and Ca2+-signalling molecules (e.g., Lo¨hn et
al., 2000; Shaw et al., 2006).
One important influence on vascular tone is the activity of large conductance Ca2+-
and voltage-activated K+ (BKCa) channels (Wray & Burdyga, 2010). Indeed, BKCa channel
dysfunction occurs in several vascular diseases including hypertension and atherosclerosis,
and pharmacological modulation of these channels is a promising avenue for novel
treatments (Fe´le´tou, 2009). BKCa channel regulation is complex and multi-factorial, with
influences including Ca2+, voltage, cellular microarchitecture, protein kinases, and the
accessory β1- subunit which enhances the Ca2+ sensitivity of the pore forming α subunit
(reviewed by Hill et al., 2010). As a consequence of this complex regulation, BKCa channels
show artery and vascular bed-specific properties (Hill et al., 2010). In cerebral resistance
arteries, SR Ca2+ release through ryanodine receptors (Ry-R) triggers Ca2+ ‘sparks’ in
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SMCs (Nelson et al., 1995). The resulting local increase in [Ca2+ ] in the sub-sarcolemmal
domain triggers activation of clusters of BKCa channels in the plasma membrane, resulting
in spontaneous transient outward currents (STOCs). These STOCs result in membrane
hyperpolarisation, closure of VDCCs and relaxation, providing a brake on myogenic tone
(Nelson et al., 1995). It is thought that caveolae allow the plasma membrane to come into
closer opposition with the superficial SR and so localised Ca2+ signalling between SR and
BKCa channels can occur in the sub-membrane domain (Lo¨hn et al., 2000; Drab et al.,
2001; Wray & Burdyga, 2010). Caveolins bind directly to BKCa channels and this likely
serves to localise them within caveolae (e.g., Yamamura et al., 2012). In contrast to cerebral
resistance arteries, some other arteries do not display this tight spark-STOC coupling. In
particular, arteries supplying skeletal muscle have BKCa channels that have lower Ca2+
sensitivity and that are not activated by sparks, and this is thought to be due to lower
expression of the β1 subunit relative to the α subunit as well as a lower overall level of
α-subunit expression (Yang et al., 2009; Yang et al., 2013; Nourian et al., 2014). Decreased
activity results in a smaller contribution of BKCa channels to the cell membrane potential
and this may in turn permit higher levels of vascular resistance in the skeletal muscle
circulation (Jackson & Blair, 1998; Hill et al., 2010).
The contribution of caveolae and BKCa channels to arterial contractility in response
to caveolar disruption are complex and artery dependent. Furthermore, a role for
endothelial-derived substances or endothelial caveolae on SMC BKCa channel activity
has not been reported. In this study, we have investigated the effects of caveolar disruption
by membrane cholesterol depletion on the contraction of rat femoral artery in vitro. Our
results are consistent with caveolar loss causing reduced NO release from ECs. Lower
NO availability results in a decrease in the contribution of BKCa channels to the SMC
membrane potential, leading to depolarisation and smooth muscle cell contraction.
Caveolar disruption has only a small direct effect on SMCs in the absence of the
endothelium in rat femoral arteries.
MATERIALS AND METHODS
Animals
Tissues were obtained from adult male Wistar rats (175–200 g; Charles River Laboratories)
which were killed by a rising concentration of CO2 followed by exsanguination. The care
and euthanasia of animals conformed to the requirements of the UK Animals (Scientific
Procedures) Act 1986.
Myography
Isometric tension of rat femoral arteries was measured in a small artery myograph (Model
500A; Danish Myotechnology, Aarhus, Denmark) as previously described (Quayle et al.,
2006). Arteries were dissected in cold 5.4 mM K+ physiological saline solution (PSS)
containing (mM): 137 NaCl, 5.4 KCl, 0.44 NaH2PO4, 0.42 Na2HPO4, 4.17 NaHCO3, 1
MgCl2, 2 CaCl2, 10 HEPES, 10 glucose, pH adjusted to 7.4 with NaOH. Ring segments
of artery were then mounted in the myograph by threading two strands of tungsten wire
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(diameter 40 µm) through the vessel lumen. After vessel mounting and equilibration
at 37 ◦C, passive tension was adjusted to allow measurement of active force production
(Mulvany & Halpern, 1977). Arteries were stimulated to contract by; (i) an 80 mM K+
containing saline (80 K), which had the composition of the 5.4 mM K+ saline except
74.6 mM NaCl was substituted with KCl, or, (ii) a 20 K/Bay K containing saline, which had
the composition of the 5.4 mM K+ saline except 14.6 mM NaCl was substituted with KCl
and that 200 nM of the dihydropyridine voltage-dependent calcium channel agonist±Bay
K8644 had been added. This solution has proved useful for inducing arterial contraction
in the absence of agonists that are coupled to receptors and second messenger pathways
(Davie, Kubo & Standen, 2008). The endothelium was removed from some arteries by
rubbing a human hair through the lumen. Removal of a functional endothelium was
confirmed by absence of relaxation to 10 µM acetylcholine.
Transmission electron microscopy
Femoral arteries were treated with 5 mM M-β-CD (n = 5) and matched with a control
group of arteries (n = 5). Both groups were cut into small pieces (about 0.5 mm3). The
segments were immediately fixed with 4% paraformaldehyde and 2.5% glutaraldehyde in
0.1 M sodium cacodylate (pH 7.4) overnight at room temperature. Next day, the samples
were rinsed three times in 0.1 M sodium cacodylate and then post-fixed in 1% (w/v)
osmium tetroxide (OsO4) in 0.1 M sodium cacodylate for 1 h. The samples were then
rinsed with 0.1 M cacodylate for 30 min, and incubated with 0.1 M cacodylate overnight.
Samples were washed with distilled water and ethanol, 30 min each, and incubated in 2%
aqueous uranyl acetate for 60 min before embedding in resin. Samples were dehydrated
through a graded series of alcohol (60, 70, 80, 90 and 100%), five minutes each. Segments
were then immersed in 100% acetone to remove water and then embedded in resin (30%
resin:70% acetone; 70% resin:30% acetone and 100% resin) for 1, 1 and 2 h, respectively.
Samples were left in the oven at 60 ◦C to polymerise overnight. Ten sections were cut
from each group (i.e., control and M-β-CD treated) at a thickness of 70–90 nm using an
ultramicrotome (Leica EM FC6). Ultrathin sections were picked up on coated copper grids
of 300-mesh, with 0.3% Pioloform and the grids dried overnight at room temperature.
Grids were then double stained with 2% aqueous uranyl acetate for four minutes, and
thereafter rinsed with distilled water for a minute, re-stained again with 0.1 M lead citrate
for four minutes, washed with distilled water for a minute and left overnight at room
temperature to dry.
Drugs and chemicals
5 mM M-β-CD was dissolved directly in the extracellular solution. 5 mM cholesterol-
saturated M-β-CD (Ch-MCD) was prepared by dissolving directly in PSS by heating at
80 ◦C for 10 min using a water bath. Filipin (4 µg/ml) was prepared by dissolving in PSS
at 37 ◦C for 10 min using a water bath. L-NAME (250 µM) was dissolved directly in PSS.
±BayK 8644 was made up as a 5 mM stock in ethanol and added to the 20 K extracellular
solution. Tetraethylammonium (TEA+) chloride and iberiotoxin (IbTX) were dissolved in
the appropriate extracellular solution.
Al-Brakati et al. (2015), PeerJ, DOI 10.7717/peerj.966 4/28
Data analysis and statistics
Data were recorded on computer using a MiniDigi analogue to digital interface in
combination with Axoscope software (Axon Instruments, Union City, California, USA).
Results were analysed using Axoscope and SigmaPlot 11. The passive or resting tension
was subtracted prior to data analysis, and active force measured in the steady state is
shown. Statistical significance was assessed by ANOVA with Tukey’s post-test comparison
or by paired Student’s t-test, using GraphPad InStat 3 software. Significance is given as
P < 0.05(∗), P < 0.01(∗∗), P < 0.001(∗∗∗) or not significant (n.s.) Data are reported as
mean± SEM, and n is the number of arteries, isolated from at least three animals.
RESULTS
Cholesterol depletion by M-β-CD disrupts caveolae in smooth
muscle and endothelial cells of rat femoral artery
M-β-CD depletes membrane cholesterol, which is essential for caveolar stability (Zidovet-
zki & Levitan, 2007). Figure 1 illustrates transmission electron micrographs of sections of
control (untreated) and M-β-CD treated rat femoral artery. Omega shaped invaginations
of the plasma membrane characteristic of caveolae were seen in control sections in both
ECs and SMCs. After treatment with M-β-CD, caveolae were seen less frequently, and
those that were present showed an opened-out, cup-like profile. These images establish
that treatment with M-β-CD disrupts caveolae of rat femoral ECs and SMCs.
Disruption of caveolae enhances femoral artery contraction
To investigate the functional role of caveolae in rat femoral artery, the effect of treatment
with M-β-CD on the contractile response to 80 K and 20 K/Bay K was recorded (Fig. 2).
Both solutions will cause contraction by membrane depolarisation and activation of
voltage-dependent calcium channels in SMCs (e.g., Meisheri, Cipkus Dubray & Oleynek,
1990; Davie, Kubo & Standen, 2008). After M-β-CD treatment, 20 K/Bay K-induced
contraction significantly increased from 11.84 ± 1.30 mN to 18.25 ± 2.00 mN (n = 12,
P < 0.01). In contrast, the contraction to 80 K was virtually identical, with a maximum
force of 33.40± 1.43 mN before and 33.16± 2.02 mN after M-β-CD treatment (n = 12,
n.s.). Filipin, a macrolide antibiotic which binds cholesterol and disrupts caveoli, also
significantly increased force in response to 20 K/Bay K (Fig. 3) (5.36 ± 1.66 mN to
9.36± 2.21 mN, n= 14, P < 0.001), but not 80 K (18.60± 2.92 to 18.73± 3.12, n.s.)
M-β-CD might have non-specific effects (Zidovetzki & Levitan, 2007). To examine
if the above results were due to caveolae disruption, we attempted to reverse the effects
of M-β-CD by subsequent incubation of arteries with cholesterol saturated M-β-CD
(Ch-MCD) (e.g., Dreja et al., 2002; Prendergast et al., 2010). Ch-MCD (5 mM, 50 min)
had no significant effect on 20 K/Bay K induced tone by itself (3.15 ± 0.45 mN to 2.98
± 0.59 mN, n = 6, n.s.). However, Ch-MCD reversed the enhancing effect of M-β-CD
on 20 K/Bay K contractions (Fig. 4), with force changing from 3.50 ± 0.61 mN in
20 K/Bay K, to 5.60 ± 1.46 mN after M-β-CD, to 3.02 ± 0.64 mN following Ch-MCD
(n= 14). Ch-MCD significant inhibited contractions to 80 K solution, with force changing
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Figure 1 M-β-CD disrupts caveolae in rat femoral artery. (A) (i) Transmission electron micrograph of
rat femoral artery showing caveolae covering most of the EC membrane. IEL is the internal elastic lamina.
Magnification was×60,000. Scale bar= 1 µm. (ii) Detail from marked area in (i) showing caveolae (Cav)
and caveosomes (V). (iii) After treatment with 5 mM M-β-CD, EC cell membrane was free of caveolae.
(B) (i) TEM of smooth muscle cell. Magnification was×60,000. Scale bar= 1 µm. (ii) Detail from marked
area in (i) showing caveolae (Cav) and mitochondrion (M). (iii) After treatment with 5 mM M-β-CD,
SMC cell membrane was free of caveolae.
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Figure 2 Effect of caveolar disruption with M-β-CD on rat femoral artery contraction. (A) Original
traces show that treatment with 5 mM M-β-CD augments contraction in response to 20 K/Bay K but not
to 80 K. (B) Mean data showing the effects of cholesterol depletion on the response to 20 K/Bay K and
80 K. Statistically significant difference was detected using Student’s t-test. n= 12.
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Figure 3 Effect of caveolar disruption with filipin. (A) Filipin treatment augments contraction in
response to 20 K/Bay K but not to 80 K. (B) Mean data showing the effects of filipin treatment on the
response to 20 K/Bay K and 80 K. Statistical significance was detected using Student’s t-test. n= 14.
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Figure 4 Ch-MCD reverses the effect of M-β-CD on contractions. (A) M-β-CD treatment augments
contraction to 20 K/ BayK and Ch-MCD reverses this effect. (B) Mean data showing the effect of M-β-CD
and Ch-MCD on 20 K/Bay K and 80 K contractions. Statistical significance was examined using ANOVA.
n= 14.
Al-Brakati et al. (2015), PeerJ, DOI 10.7717/peerj.966 9/28
from 16.72 ± 2.05 mN in 80 K to 13.55 ± 2.20 mN in 80 K in the presence of Ch-MCD
(n= 14, P < 0.001).
The effect of M-β-CD on force is endothelium-dependent
Caveolar disruption has been reported to reduce endothelium-dependent vasodilation
but it can also alter contraction by directly acting on SMCs (see Introduction). In order
to distinguish these two possibilities, ECs were mechanically removed and absence of a
functional endothelium confirmed for each artery by a lack of a vasodilator response to
10 µM acetylcholine. Endothelial removal reduced the ability of M-β-CD to enhance
contractions to 20 K/Bay K (Fig. 5) (6.62 ± 0.92 mN to 7.52 ± 1.03 mN after M-β-CD,
n = 22, n.s.). The results indicate that M-β-CD acts on endothelium where it alters release
of an endothelial-derived vasodilator or vasoconstrictor.
L-NAME enhances 20 K/Bay K contractions but has no effect after
M-β-CD treatment
One candidate for an endothelial factor influencing SMC contraction is NO. When arteries
were pre-incubated with the eNOS inhibitor L-NAME (250 µM) the contraction to
20 K/Bay K was enhanced (Fig. 6) (6.82± 1.61 mN to 14.90± 2.67 mN, n = 6, P < 0.001).
However, after M-β-CD treatment, L-NAME no longer had a significant effect on the
response to 20 K/Bay K (17.74± 3.46 mN to 16.10± 3.19 mN, n = 6, n.s). This result is
consistent with the hypothesis that caveolar disruption by M-β-CD results in decreased
release of NO from the endothelium.
Effect of L-NAME on femoral artery responses to phenylephrine
Contraction induced with 20 K/Bay K has the advantage of being relatively simple in mech-
anism, by-passing receptors and second messenger systems. However, it may not reflect
events occurring during more physiological contractions. To address whether basal release
of NO occurred in the presence of a physiological stimulus the effect of L-NAME was
examined in arteries contacted with the α-adrenergic agonist, phenylephrine. Contraction
was triggered with cumulative doses of phenylephrine (PE) (0.1–30 µM) (Fig. S1). Arteries
were then pre-incubated with L-NAME (250 µM) for 10 min and phenylephrine applied
in the presence of L-NAME. A given concentration of phenylephrine was more effective
after L-NAME treatment, and concentration–response curves were shifted to the left
(Fig. S1). This results suggests endothelial NO synthesis also occurs during phenylephrine
contractions in these arteries.
Effect of inhibition of BKCa channels by TEA+ and iberiotoxin on
the response to M-β-CD
M-β-CD augmented the response to 20 K/Bay K but not to 80 K (see Fig. 2). In 80 K
solution the cell membrane potential will lie close to the equilibrium potential for K+. In
this case, opening of K+ channels will not lead to hyperpolarisation, and the inability of a
substance to cause relaxation in 80 K solution may implicate K+ channel activation in va-
sodilation (e.g., Meisheri, Cipkus Dubray & Oleynek, 1990). One explanation for our data is
therefore that NO release from the endothelium causes SMC relaxation via K+ channel ac-
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Figure 5 Effect of M-β-CD on endothelium-denuded femoral artery. (A) After endothelial removal
incubation with M-β-CD did not augment contractions to 20 K/Bay K. Absence of a functional endothe-
lium was shown by lack of relaxation to ACh. (B) Mean data showing no significant difference in the
contractions of endothelium-denuded arteries stimulated with 20 K/Bay K following M-β-CD treatment.
Statistical significance was examined using Student’s t-test. n= 22.
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Figure 6 Effect of inhibition of NO synthase by L-NAME. (A) Incubation with 250 µM L-NAME
augmented contraction response to 20 K/Bay K. When arteries were incubated with M-β-CD, contraction
with 20 K/Bay K was enhanced. However, L-NAME no longer had an additional contractile effect after
M-β-CD treatment. (B) Mean data showing 250 µM L-NAME significantly increases the contraction
response to 20 K/Bay K. L-NAME did not enhance the contraction after M-β-CD treatment. Statistical
significance was examined using ANOVA. n= 6.
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tivation. In order to test this, the effect of the BKCa channel inhibitors TEA+ and IbTX was
investigated before and after caveolar disruption with M-β-CD. BKCa channels have been
previously implicated in NO-induced vasodilation (e.g., Kahn, Higdon & Meisheri, 1998).
Initially, 2 mM TEA+ was used to inhibit BKCa channels, and at this concentration
it can be regarded as selective (Langton et al., 1991). TEA+ increased resting force from
1.15 ± 0.68 mN to 2.15 ± 0.81 mN (n = 8, ns, Fig. 7). In some experiments, including
that illustrated in Fig. 7, spikes were superimposed on top of the increase in resting force,
indicating TEA+ is inducing spontaneous oscillations in this vessel. 2 mM TEA+ applica-
tion significantly increased the contraction with 20 K/Bay K from 7.07± 2.05 mN to 18.53
± 3.25 mN (n= 8, P < 0.05). These results suggest TEA+-sensitive K+ channels contribute
to the membrane potential at both resting state and during contraction with 20 K/Bay
K. Incubating arteries with 5 mM M-β-CD augmented contraction to 20 K/Bay K, as
previously shown (7.07± 2.05 mN to 15.29± 2.84 mN; n = 8, P < 0.01). After treatment
with M-β-CD, TEA+ no longer caused significant additional contraction to 20 K/Bay K
(15.29± 2.84 mN to 19.54± 2.22 mN; n= 8, ns). The observation that TEA+ significantly
increased force before, but not after, M-β-CD treatment suggests caveolar disruption
decreases the contribution of a TEA+-sensitive K+ channel to the membrane potential.
In endothelium-denuded arteries, 2 mM TEA+ caused a small but non-significant
increase in 20 K/Bay K contraction (from 6.06 ± 1.44 mN to 8.01 ± 1.58 mN; n = 8,
ns, Fig. 8). M-β-CD application had no significant effect on 20 K/Bay K contraction in
endothelium-denuded arteries, as previously shown (6.06± 1.44 mN to 6.19± 1.32 mN;
n = 8, ns). After endothelium-denuded arteries were incubated with M-β-CD, TEA+
caused a small, non-significant, additional contraction in response to 20 K/Bay K, from
6.19± 1.32 mN to 7.23± 1.61 mN (n= 8, ns).
The experiments with TEA+ were repeated with the more selective BKCa channel
inhibitor iberiotoxin (IbTX) (Fig. 9). Incubating arteries with 100 nM IbTX augmented
contraction to 20 K/Bay K (5.13± 0.93 mN to 11.60± 1.84 mN; n = 6, P < 0.01). After
endothelial removal, incubation of arteries with 100 nM IbTX no longer significantly
enhanced 20 K/Bay K contractions (6.76± 0.88 mN to 8.30± 1.15 mN, n= 6, ns).
Overall, the results with TEA+ and IbTX indicate that inhibition of BKCa channels
increases contraction to 20 K/Bay K in rat femoral artery. Endothelium removal largely
abolishes this effect, as does caveolar disruption by treatment with M-β-CD. Both M-β-
CD treatment and removal of endothelium may inhibit endothelial NO release. NO is a
known activator of BKCa channels in SMCs, so reduced release may decrease BKCa channel
activity, leading to SMC depolarization and contraction.
Effects of IbTX on tone are reduced by inhibition of basal NO
release
Further experiments were designed to examine whether the effects of L-NAME and IbTX
on contraction were additive, an indication that two mechanisms act through different
pathways. Adding IbTX (100 nM) at the peak of the 20 K/Bay K contraction induced
significant further contraction (Fig. 10). When arteries were pre-treated with L-NAME, the
20 K/Bay K contractions were enhanced, again consistent with previous observations, but
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Figure 7 Effect of TEA+ on 20 K/Bay K contractions. (A) Incubation of arteries with 2 mM TEA+
increased basal tone, and also augmented the response to 20 K/Bay K. M-β-CD caused an enhanced
contraction in response to 20 K/Bay K, but this effect of M-β-CD was absent in the presence of TEA+.
(B). Mean data for effect of TEA+ on femoral artery contractions to 20 K/Bay K before and after M-β-CD
treatment. Data show a significant increase in the contraction in response to 20 K/Bay K after incubation
of the artery with 2 mM TEA+ before, but not after, treatment with M-β-CD. Statistical significance was
examined using ANOVA. n= 8.
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Figure 8 Effect of TEA+ on 20 K/Bay K contractions in an endothelium-denuded artery. (A) 2 mM
TEA+ had little effect on 20 K/Bay K contractions in endothelium-denuded artery. (B) Mean data
showing a non-significant increase in the contraction response to 20 K/Bay K by TEA+. Statistical
significance was examined using ANOVA. n= 8.
Al-Brakati et al. (2015), PeerJ, DOI 10.7717/peerj.966 15/28
Figure 9 Effect of IbTX on 20 K/Bay K contractions. (A) Original trace shows incubation of artery with
100 nM IbTX augments contraction in response to 20 K/ Bay K. After endothelial removal, IbTX was
no longer effective at increasing force. (B) Mean data showing an increase in the contraction response to
20 K/Bay K after incubation of the artery with IbTX. Statistical significance was examined using Student’s
t− test. n= 6.
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Figure 10 Combined effect of IbTX and L-NAME on 20 K/Bay K contractions. (A) Addition of 100 nM
IbTX induced further contraction to 20 K/Bay K. When arteries were pre-incubated with 250 µM
L-NAME, IbTX was less effective in increasing force. (B). Mean data showing a significant increase in
contraction response to 20 K/Bay K by IbTX before, but not after, incubation with L-NAME. Statistical
significance was established using Student’s t-test. n= 8.
the contractile effect of IbTX was now much smaller. IbTX (100 nM) caused additional
contraction over and above that caused by 20 K/Bay K of 6.86 ± 0.81 mN and 3.50
± 0.55 mN (n = 8) in the absence and presence of L-NAME, respectively. Once again,
this result is consistent with NO release from the endothelium causing activation of BKCa
channels in vascular SMCs, and that inhibiting NO synthesis with L-NAME or BKCa
channels with IbTX therefore has a similar overall effect on force.
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Figure 11 Effect of TEA+ on SNP-induced relaxation in endothelium-denuded femoral artery. (A)
Traces showing vasorelaxation in an artery contracted by 20 K/Bay K. SNP (0.1–100 µM) produced
relaxation before and after treatment with 2 mM TEA+; (B) Trace showing vasorelaxation produced by
SNP (0.1–100 µM) in an artery contracted with 80 K. (C) Concentration-response curves for relaxations
induced by SNP in arteries contracted with 20 K/Bay K in the absence (•) and presence (◦) of 2 mM
TEA+, and in arteries contracted with 80 K (▼).
NO donors relax rat femoral arteries partly via activation of BKCa
channels
NO and other guanylate cyclase coupled vasodilators exert their effect in part through
activation of BKCa channels in some arteries (e.g., Kahn, Higdon & Meisheri, 1998;
Robertson et al., 1993). In rat femoral arteries, the NO donor sodium nitroprusside (SNP)
caused vasorelaxation, and this relaxation was attenuated in the presence of 2 mM TEA+
(Fig. 11). The vasorelaxation response to SNP was significantly inhibited by TEA+ at
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concentrations of SNP of 1 µM and above (1 µM SNP, P < 0.01; 3–100 µM SNP, P < 0.001,
n = 8). Furthermore, vasorelaxation in response to SNP was also attenuated in arteries
contracted with 80 K solution (1 µM SNP, P < 0.01; 3–100 µM SNP, P < 0.001, n = 8).
These results suggest that NO donors cause relaxation of rat femoral artery partly though
activation of BKCa channels.
DISCUSSION
The caveolar disrupting agents M-β-CD and filipin both enhanced contraction of rat
femoral arteries in response to 20 K/Bay K (Figs. 2 and 3). In the case of M-β-CD, the
contraction was reversed by Ch-MCD (Fig. 4), and depended on an intact endothelium
(Fig. 5). Arteries also showed enhanced contractions to 20 K/Bay K when NO synthesis
was inhibited by L-NAME (Fig. 6). However, L-NAME did not augment 20 K/Bay K
contractions following pre-treatment with M-β-CD. The BKCa channel inhibitors TEA+
and IbTX both enhanced contractions to 20 K/Bay K, and the effect of these agents was
much reduced after removal of the endothelium or M-β-CD treatment (Figs. 7 and 8
and 9). Relaxations to the NO donor SNP were attenuated by inhibition of BKCa channels
with TEA+ (Fig. 11). Taken together, these results suggest that caveolar disruption in
rat femoral arteries results in a reduced NO release from ECs, and that this enhances
arterial contraction due a reduced contribution of BKCa channels to the smooth muscle cell
membrane potential.
Effect of caveolar disruption on endothelium-dependent
vasodilation
Caveolae are specialised membrane domains characterised by a high cholesterol and
sphingolipid content, and by the presence of the signature proteins the caveolins (Rothberg
et al., 1992; Cohen et al., 2004). Caveolin-1 is necessary and sufficient to drive caveolar for-
mation and knockout of caveolin-1 results in caveolar loss (Drab et al., 2001). Caveolin-2 is
generally co-expressed with caveolin-1, with which it forms hetero-oligomeric complexes.
Caveolin-2 appears to have a supporting role in caveolar formation (Sowa et al., 2003).
Caveolin-3 is muscle specific and most muscle cells exclusively express caveolin-3, where it
has roles analogous to caveolin-1 in non-muscle cells (Cohen et al., 2004). Vascular smooth
muscle is unusual in expressing all three caveolin isoforms (Cohen et al., 2004; Kamishima
et al., 2007). Caveolae have been shown to be important in physiological regulation of
arterial tone, and disruption of caveolae may be a factor in vascular pathologies, including
atherosclerosis (Darblade et al., 2001; Xu et al., 2008; Prendergast et al., 2014).
One particularly well characterised function of caveolae and the caveolins is in the
regulation of the activity of endothelial nitric oxide synthase. Caveolin-1 binds to eNOS
through a scaffolding domain, and this causes tonic inhibition of enzyme activity (Michel
et al., 1997a). This inhibition is relieved in the presence of Ca2+-calmodulin (Ca2+-CaM),
and endothelial Ca2+ is therefore is a major regulator of NO synthesis (Michel et al.,
1997b). Many factors stimulate NO production by increasing cytoplasmic Ca2+, including
endothelium-dependent vasodilators like acetylcholine (Michel & Vanhoutte, 2010).
The functional effects of caveolin-1 loss have been addressed by gene knockout
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(Drab et al., 2001). Arteries from caveolin-1 knockout (cav1-/-) mice have an enhanced
response to the endothelium-dependent vasodilator acetylcholine, and have increased
basal NO release (Drab et al., 2001; Razani et al., 1990). Both effects are consistent with the
reported tonic inhibition of eNOS activity by caveolin-1.
The role of caveolae in vascular function has also been addressed by pharmacological
disruption of caveolae by cholesterol depleting agents such as M-β-CD and filipin
(Zidovetzki & Levitan, 2007; Rothberg et al., 1992; this study). In contrast to the studies
on caveolin knockout animals discussed above, many studies have shown that disruption
of caveolae by cholesterol depleting agents reduces the response to endothelium-dependent
vasodilators such as acetylcholine (e.g., Darblade et al., 2001; Graziani et al., 2004;
Linder et al., 2005; Xu et al., 2007). Caveolar disruption inhibits both NO-mediated
and endothelial-derived hyperpolarizing factor (EDHF)-mediated vasodilation. In the
case of NO-mediated vasodilation, disruption of caveoli by M-β-CD may result in (i)
re-distribution of eNOS to non-caveolar membranes that contain caveolin-1, which then
further inhibits eNOS activity, (ii) loss of local caveolar signalling pathways required to
efficiently couple vasodilator-receptor binding to eNOS activation (Xu et al., 2007). It is
possible similar mechanisms may be responsible for the effects we observed for M-β-CD
in rat femoral artery. We have not specifically looked for EDHF-mediated responses in rat
femoral artery. However, the NOS inhibitor L-NAME abolished the vasodilator response
to ACh (Fig. 6), suggesting that NO is the main mediator of the response in these vessels.
EDHF may become more important in resistance-sized arteries (see e.g., Hill et al., 2010;
Garland, Hiley & Dora, 2011).
It should be noted that the agents we have used to deplete membrane cholesterol
(M-β-CD, filipin) will also affect other (non-caveolar) lipid rafts (Zidovetzki & Levitan,
2007). However, given the well-documented localisation of eNOS within caveolae it seems
more likely that our results can be understood in terms of the effects on this cellular
structure.
Ch-MCD reversed the effects of M-β-CD, suggesting the effect was mediated by
cholesterol depletion (Fig. 4). Interestingly, Ch-MCD significantly reduced contraction
to 80 K solution. In this study we were focused on the effects of cholesterol depletion,
and we have not investigated the basis for the effect of Ch-MCD further, but cholesterol
has been shown to directly inhibit K+-induced contractions of rat aorta by inhibiting
voltage-dependent Ca2+ currents (A´lvarez et al., 2010). Cholesterol has also been reported
to have a variety of direct, usually inhibitory, effects on ion channels (reviewed by Levitan,
Singh & Rosenhouse-Dantsker, 2014).
Direct effects of caveolar disruption on smooth muscle cell
contraction
Disruption of caveolae in SMCs has previously been shown to modify the response to some
receptor-coupled vasoconstrictors (e.g., Dreja et al., 2002; Clarke, Ohanian & Ohanian,
2007; Potoknik et al., 2007; Prendergast et al., 2010), and also reduces the myogenic response
to increased intravascular pressure (e.g., Adebiyi et al., 2007; Dubroca et al., 2007; Potoknik
et al., 2007). Generally, these results have been interpreted as providing evidence for the
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importance of a caveolar location for receptors, signalling molecules or ion channels
that are involved in the contractile response. In rat femoral artery caveolar depletion had
relatively modest effects on contraction to 20 K/Bay K in the absence of the endothelium
(Fig. 5), despite the presence of caveolae in SMCs (Fig. 1). Disruption of SMC caveolae may
not have a major effect on contraction in these arteries.
Basal NO release in rat femoral artery
Several studies have addressed the effect of caveolar disruption on relaxations to
endothelium-dependent vasodilators such as acetylcholine (e.g., Darblade et al., 2001; Xu et
al., 2008). Our study looked at the effect of caveolar disruption on NO mediated responses
that occur in the absence of an endothelium-dependent receptor-coupled vasodilator.
The eNOS inhibitor L-NAME increased contractions triggered by 20 K/Bay K (Fig. 6).
PE concentration–response curves were also shifted to the right by pre-incubation of
arteries in L-NAME (Fig. S1). Both observations are consistent with substantial basal NO
release without an application of endothelium-dependent vasodilator in these arteries.
Generally, NO synthesis by endothelial cells is low in the absence of a stimulating factor
such as an endothelium-dependent vasodilator or flow. This is likely due to tonic and
almost complete inhibition of eNOS activity by caveolin-1 in the absence of Ca2+–CaM
(Michel & Vanhoutte, 2010). However, basal NO release does occur and may be particularly
important in large arteries (e.g., Martin et al., 1986; Fleming et al., 1999). The mechanisms
of such a basal NO release have been debated and several hypotheses have been advanced.
Lumenal flow can trigger NO release via Akt-induced phosphorylation and activation of
eNOS, and this is likely to be important in vivo (reviewed in Fleming, 2010). However, our
experiments were conducted in the absence of flow, so this seems unlikely to contribute to
basal NO release in our study. Isometric contraction may by itself induce the activation of
eNOS and so NO production (Fleming et al., 1999). Contraction is associated with a rise
in vascular smooth muscle cell Ca2+ concentration, and this can, in turn, bring about a
rise in endothelial cell Ca2+, so triggering Ca2+-dependent activation of eNOS activity and
subsequent NO release (Dora, Doyle & Duling, 1997; Dora et al., 2000; Jackson et al., 2008).
Ca2+ may move directly from smooth muscle to endothelial cells via myo-endothelial gap
junctions (Dora, Doyle & Duling, 1997). Such a mechanism may contribute to the basal NO
release observed in our study.
Role of K+ channels in the response to M-β-CD
Whilst contraction to 20 K/Bay K was enhanced by M-β-CD and filipin treatment, that to
80 K was unaltered (Figs. 2 and 3). When extracellular K+ is raised to 80 mM, the mem-
brane potential of the cell is depolarised and approaches the K+ equilibrium potential, and
so K+ channel opening will not cause membrane potential hyperpolarisation or relaxation
through closure of VDCCs. Thus if a reduced responsiveness to a vasodilator is seen as the
extracellular [K+ ] is elevated this can be taken as evidence for the involvement of K+ chan-
nels in smooth muscle cell in the response (e.g., Meisheri, Cipkus Dubray & Oleynek, 1990).
It should be noted that raising extracellular K+ would also lower the driving force
for Ca2+ entry into the endothelial cell, which by itself may decrease basal NO release.
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However, further experiments showed that 20 K/Bay K contractions were enhanced
by TEA+ and IbTX, both BKCa channel inhibitors (Figs. 7, 9 and 10). This effect
of TEA+ and IbTX was lost if the endothelium was removed (Figs. 8 and 9). When
arteries were pre-incubated in L-NAME the contractile effect of IbTX was considerably
reduced (Fig. 10). The simplest explanation for our data is that endothelial-derived
NO normally has a tonic inhibitory effect on femoral artery contraction via SMC BKCa
channel activation. Nitrovasodilators are known to cause vasorelaxation through K+
channel opening. For instance, nitroglycerin becomes a less effective relaxant of dog
coronary artery as extracellular K+ is elevated, and the relaxations in physiological K+
are reduced by pharmacological inhibition of BKCa channels by charybdotoxin and
iberiotoxin (Kahn, Higdon & Meisheri, 1998). The pathway for regulation of BKCa channels
by nitrovasodilators may involve activation of guanylate cyclase, generation of cGMP,
activation of cGMP-dependent protein kinase and subsequent opeining of SMC BKCa
channels (Robertson et al., 1993). In rat femoral artery inhibition of BKCa channels with
TEA+, and elevation [K+]o to 80 mM, reduced the ability of the NO donor sodium
nitroprusside to cause relaxation (Fig. 11).
Endothelial BKCa channels
An alternative explanation for the contractile effects of IbTx (Figs. 9 and 10) is that
inhibition of BKCa channels by this compound depolarises the endothelial cell membrane
potential. In ECs the consensus view is that the presence of voltage-independent Ca2+
‘leak’ pathways means that membrane depolarisation will lead to a fall in Ca2+ concen-
tration due to an decrease in the driving force for Ca2+ entry into the cell (reviewed by
Dora & Garland, 2013, though see Bossu et al., 1992). This would reduce Ca2+-dependent
activation of eNOS, decrease NO release and so enhance arterial contraction. There are
numerous reports of the presence of BKCa channels in endothelial cells (reviewed in
Sandow & Grayson, 2009). However, their presence is not universally accepted and it has
been argued that they have mainly been reported in cultured cells and are not present in
the endothelium of non-diseased arteries (Sandow & Grayson, 2009). In the context of
the current study it is interesting to note that BKCa channels in cultured bovine aortic
endothelial cells (BAECs) cannot be recorded in resting conditions, but that they become
active after cholesterol depletion (Wang et al., 2005). In BAECs, caveolin-1 appears to
directly interact with and inhibit the activity of endothelial BKCa channels. Interestingly,
endothelial BKCa channels activity can also be induced by activation of endothelial
β-adrenoreceptors or by chronic hypoxia, and in both cases this occurs via release of
caveolin-1 inhibition of channel activity (Wang et al., 2005; Riddle, Hughes & Walker,
2011). Further electrophysiological experiments will be required to determine whether
BKCa channels are present in rat femoral artery endothelial cells, or if their activity can be
modulated by cholesterol depletion.
Role of BKCa channels in regulating femoral artery tone
In our study, inhibiting BKCa channels with TEA+ or IbTX enhanced 20 K/Bay K
contractions in endothelium-intact arteries more than two-fold (Figs. 7, 9 and 10), but
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only by about 25% in endothelium-denuded arteries (Figs. 8 and 9). Clearly BKCa channels
contribute to the membrane potential in both conditions, and the results are consistent
with the well-documented role of BKCa channels in providing negative feedback inhibition
in conditions of tone generation (e.g., Nelson et al., 1995; Hill et al., 2010). However,
the substantially larger contraction seen in the presence of an intact endothelium may
mean endothelial NO is a major driver of BKCa channel activity in rat femoral arteries.
Interestingly BKCa channels appear to make a relatively small contribution to membrane
potential and resting tone in the arteries supplying the rat cremaster muscle, partly due
to a low Ca2+- sensitivity of the channel (Jackson & Blair, 1998). BKCa channels form as a
heterotetramer of pore forming α subunits, with the accessory β subunits enhancing the
Ca2+-sensitivity of the channel. The low Ca2+ sensitivity of the BKCa channel in cremaster
arterioles may derive from a relative lack of β-subunit expression in this artery (Yang
et al., 2009). Our data suggests the contribution of the BKCa channel to the membrane
potential and contraction in femoral artery can be enhanced by endothelial derived NO,
adding another factor that must be considered when assessing the role of this channel
in the skeletal muscle vasculature. Regional variation in the regulation of BKCa channels
is likely to be important in fine control of vascular contractility in accordance with the
physiological function of the tissue (Hill et al., 2010; Yang et al., 2013).
CONCLUSIONS
Caveolar disruption in rat femoral artery results in contraction due to decreased release
of endothelial-derived NO. The mechanism may involve a reduced contribution of BKCa
channels to the smooth muscle cell membrane potential. Endothelial-derived NO appears
to be a major influence on the BKCa activity in SMCs in these arteries, and this observation
adds to our understanding of the complex regulation of KCa channel activity in the skeletal
vasculature.
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